These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9816630)

  • 21. False positive labeling of prostate cancer with high molecular weight cytokeratin: p63 a more specific immunomarker for basal cells.
    Ali TZ; Epstein JI
    Am J Surg Pathol; 2008 Dec; 32(12):1890-5. PubMed ID: 18813120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia.
    Minardi D; Galosi AB; Dell'Atti L; Hanitzsch H; Mario P; Muzzonigro G
    Scand J Urol Nephrol; 2002; 36(5):323-9. PubMed ID: 12487735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarrays.
    Sanderson SO; Sebo TJ; Murphy LM; Neumann R; Slezak J; Cheville JC
    Am J Clin Pathol; 2004 Feb; 121(2):220-5. PubMed ID: 14983935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Histological investigation of prostate cancer treated with hormonal agents].
    Azumi M; Saga Y; Hashimoto H; Kakizaki H
    Hinyokika Kiyo; 2006 Oct; 52(10):781-4. PubMed ID: 17131867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-grade prostatic intraepithelial neoplasia in needle biopsy as risk factor for detection of adenocarcinoma: current level of risk in screening population.
    Gokden N; Roehl KA; Catalona WJ; Humphrey PA
    Urology; 2005 Mar; 65(3):538-42. PubMed ID: 15780372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from benign epithelial lesions of the prostate.
    Shah IA; Schlageter MO; Stinnett P; Lechago J
    Mod Pathol; 1991 Mar; 4(2):220-4. PubMed ID: 1710806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Value of the prostatic puncture biopsy in the diagnosis of prostatic cancer. Apropos of 271 cases].
    Perrin P; Mouriquand P; Delorme E; Grisard M; Dutrieux-Berger N; Dassonville F
    J Urol (Paris); 1986; 92(9):601-4. PubMed ID: 2434575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of restaining prostate needle biopsies with high-molecular weight cytokeratin.
    Dardik M; Epstein JI
    Hum Pathol; 2000 Sep; 31(9):1155-61. PubMed ID: 11014585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telomerase reverse transcriptase subunit immunoreactivity: a marker for high-grade prostate carcinoma.
    Iczkowski KA; Pantazis CG; McGregor DH; Wu Y; Tawfik OW
    Cancer; 2002 Dec; 95(12):2487-93. PubMed ID: 12467061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limiting the diagnosis of atypical small glandular proliferations in needle biopsies of the prostate by the use of immunohistochemistry.
    Helpap B; Köllermann J; Oehler U
    J Pathol; 2001 Mar; 193(3):350-3. PubMed ID: 11241415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Foamy gland microcarcinoma in needle prostatic biopsy.
    Arista-Nasr J; Martinez-Benitez B; Camorlinga-Tagle N; Albores-Saavedra J
    Ann Diagn Pathol; 2008 Oct; 12(5):349-55. PubMed ID: 18774498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy.
    Borboroglu PG; Sur RL; Roberts JL; Amling CL
    J Urol; 2001 Sep; 166(3):866-70. PubMed ID: 11490235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care.
    Epstein JI; Herawi M
    J Urol; 2006 Mar; 175(3 Pt 1):820-34. PubMed ID: 16469560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate cancer detection in men with an initial diagnosis of atypical small acinar proliferation.
    Mancuso PA; Chabert C; Chin P; Kovac P; Skyring T; Watt WH; Napaki S
    BJU Int; 2007 Jan; 99(1):49-52. PubMed ID: 17227491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preneoplastic lesions of the prostate-clinical, pathological and molecular biological aspects.
    Nasir A; Copeland J; Gillespie JW; Chughtai OR; Andrawis R; Kaiser HE; Manyak MJ
    In Vivo; 2002; 16(6):557-66. PubMed ID: 12494901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial atrophy on prostate needle biopsy cores: a morphologic and immunohistochemical study.
    Wang W; Sun X; Epstein JI
    Am J Surg Pathol; 2008 Jun; 32(6):851-7. PubMed ID: 18408595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate.
    Montironi R; Mazzucchelli R; Lopez-Beltran A; Cheng L; Scarpelli M
    Nat Clin Pract Urol; 2007 Jun; 4(6):321-32. PubMed ID: 17551536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
    Zhao J; Epstein JI
    Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic effect of an improved preembedding method of prostate needle biopsy specimens.
    Rogatsch H; Moser P; Volgger H; Horninger W; Bartsch G; Mikuz G; Mairinger T
    Hum Pathol; 2000 Sep; 31(9):1102-7. PubMed ID: 11014578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.